Clinical Trial Update: An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)

View source ↗

Summary

Completed observational trial evaluating the effectiveness of adalimumab on health and disability outcomes in immune-mediated inflammatory diseases including Cr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie | Conditions: Crohn's Disease, Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2019-06-19